Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05HNO
|
||||
Former ID |
DNC008680
|
||||
Drug Name |
3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530576] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H22N2O3
|
||||
Canonical SMILES |
C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC(=CC=C3)C(=O)N
|
||||
InChI |
1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24)
|
||||
InChIKey |
ROFVXGGUISEHAM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530576] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.